I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Schuchter, F
9
results:
OpenAccess-fulltext X
english X
Search for persons
X
Sorted by: Year
Sorted by: Relevance
?
1
Phase I Trial of Autologous RNA-electroporated cMET-directe..:
Shah, Payal D
;
Huang, Alexander C
;
Xu, Xiaowei
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167933/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
2
BAMM (BRAF Autophagy and MEK inhibition in Melanoma): A pha..:
Mehnert, Janice M
;
Mitchell, Tara
;
Huang, Alexander C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923957/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
3
Exosomal PD-L1 Contributes to Immunosuppression and is Asso..:
Chen, Gang
;
Huang, Alexander C
;
Zhang, Wei
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095740/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
4
Long-term outcomes of a phase I study of agonist CD40 antib..:
David L. Bajor
;
Rosemarie Mick
;
Matthew J. Riese
...
http://dx.doi.org/10.1080/2162402X.2018.1468956. , 2018
Link:
https://doi.org/10.1080/..
?
5
Long-term outcomes of a phase I study of agonist CD40 antib..:
Bajor, David L
;
Mick, Rosemarie
;
Riese, Matthew J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169575/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
6
Sequential administration of nivolumab and ipilimumab with ..:
Weber, Jeffrey S
;
Gibney, Geoff
;
Sullivan, Ryan J
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474305/. , 2016
Link:
http://www.ncbi.nlm.nih...
?
7
Circulating Tumor Cells, DNA, and mRNA: Potential for Clini..:
Xu, Melody J
;
Dorsey, Jay F
;
Amaravadi, Ravi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709205/. , 2016
Link:
http://www.ncbi.nlm.nih...
?
8
Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) ..:
Johnson, Douglas B
;
Flaherty, Keith T
;
Weber, Jeffrey S
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226803/. , 2014
Link:
http://www.ncbi.nlm.nih...
?
9
Phase II trial of temozolomide and sorafenib in advanced me..:
Amaravadi, Ravi K
;
Schuchter, Lynn M
;
McDermott, David F
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795076. , 2009
Link:
http://www.ncbi.nlm.nih...
1-9